Presentation Information

[S1-4]Identification and Characterization of Ensitrelvir as an Oral Antiviral for SARS-CoV-2: Preclinical Efficacy and Broad Anti-Coronavirus Potential

○Michihito Sasaki1,2, Akihiko Sato1,2,3, Hirofumi Sawa1,2, Yasuko Orba1,2 (1. International Institute for Zoonosis Control, Hokkaido University (Japan), 2. Institute for Vaccine Research and Development, Hokkaido University (Japan), 3. Laboratory for Drug Discovery & Disease Research, Shionogi & Co., Ltd. (Japan))

Password required to view


Comment

To browse or post comments, you must log in.Log in